Accuryn Medical
PrivateLast Round
Private Equity
Feb 8, 2024
Est. Valuation
$122.54M
Total Funding Raised
$103.25M
Company Overview
Accuryn Medical is a healthcare technology company that develops a predictive health monitoring system for critical care settings, utilizing smart sensors and artificial intelligence to automate urine output, intra-abdominal pressure, and core body temperature measurements.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accuryn Medical Comparables
Compare Accuryn Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardioRenal Systems | 87% | |
| Fize Medical | 85% | |
| RenalSense Ltd. | 83% |
Accuryn Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Feb 8, 2024 | ||||
| Series D | Apr 7, 2023 | ||||
| Series C Extension | Oct 29, 2019 | ||||
| Series C Extension | Jul 12, 2019 | ||||
| Series C | Jul 9, 2018 | ||||
Series B | Aug 7, 2017 |
Accuryn Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scientific Health Development | Seed, Series D |
| NIH RADx | Grant |
| TheraNova | Seed |
| U.S. Department of War | Grant |
| GT Healthcare Capital Partners | Series C |
| Sonder Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 21, 2025
Todd Dunn appointed as the new Chief Executive Officer.
- Feb 8, 2024
Raised $10M in a Private Equity round.
Accuryn Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Accuryn Medical's valuation, stock price, and market status.
Is Accuryn a public or private company?
Accuryn is a private company.
What is the current stock price of Accuryn?
Accuryn is a private company with no public stock price. No recent secondary market data is available.
How much is Accuryn worth (valuation)?
Valuation information for Accuryn is not publicly available.
Can I buy Accuryn stock?
Accuryn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Accuryn's last funding round?
Accuryn's most recent funding round was Corporate Funding on February 8, 2024.
Who are the main investors in Accuryn?
Key investors in Accuryn include GT Healthcare Capital Partners, Sonder Capital.
Will Accuryn IPO soon?
No public IPO plans have been announced for Accuryn.
How can I track Accuryn secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Accuryn's secondary market activity and sign up for updates.